Business Context and Reporting Period
Company: Thermo Electron Corporation (now Thermo Fisher Scientific Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: July 3, 1999 (Second Quarter of Fiscal Year 1999)
Business Overview: A diversified manufacturer of scientific instruments, equipment, and services operating through four primary segments: Measurement and Detection, Biomedical and Emerging Technologies, Energy and Environment, and Recycling and Resource Recovery.
Key Financial Metrics
| Metric (in thousands) | Q2 1999 | Q2 1998 | 6-Month 1999 | 6-Month 1998 |
|---|---|---|---|---|
| Total Revenues | $1,092,340 | $947,799 | $2,101,878 | $1,892,062 |
| Operating Income (Loss) | $(336,055) | $105,484 | $(265,337) | $197,881 |
| Net Income (Loss) | $(235,188) | $61,785 | $(206,889) | $127,278 |
| Diluted EPS | $(1.49) | $0.34 | $(1.32) | $0.71 |
| Cash from Operations (6-Mo) | $90,136 | $132,210 | ||
| Cash & Equivalents (End of Period) | $386,864 | $396,670 (Jan 2, 1999) | ||
| Total Debt (Current + Long-Term) | $2,155,682 | $2,159,602 (Jan 2, 1999) |
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 15% in Q2 1999 and 11% for the six-month period compared to 1998, driven primarily by acquisitions (notably Spectra-Physics AB) and growth in the Measurement and Detection segment.
- Profitability Collapse: The company reported a significant operating loss of $336.1 million in Q2 1999, a sharp reversal from an operating income of $105.5 million in Q2 1998. This was primarily due to $391.3 million in restructuring and other nonrecurring costs.
- Segment Performance:
- Measurement and Detection: Revenues up 30%; segment income margin declined to 10.1% (excluding restructuring) due to lower-margin acquisitions and weakness in the semiconductor industry.
- Biomedical: Revenues up 6%; segment loss of $157.1 million driven by $142.3 million in restructuring charges, including the exit of the ThermoLase spa business and inventory provisions at Trex Medical following an FDA denial.
- Energy and Environment: Revenues flat; segment loss of $175.2 million driven by $189.2 million in restructuring charges, largely due to the closure of the Gillette, Wyoming facility and impairment of the Delano biomass facility.
- Acquisitions: Completed the acquisition of Spectra-Physics AB for approximately $347.2 million in Q1 1999. Acquired 29.4% of FLIR Systems, Inc. in connection with the Spectra-Physics deal.
Guidance, Outlook, Risks, and Unusual Items
Restructuring and Unusual Items
- Restructuring Charges: Total restructuring and related costs for Q2 1999 were $418.8 million. Key components include:
- ThermoLase: $67.7 million charge to exit the spa and hair-removal businesses.
- Thermo Ecotek: $124.3 million charge to close the Gillette facility and terminate power sales agreements at Delano.
- Thermo TerraTech: $55.9 million charge to sell several businesses including used-oil processing and soil-recycling facilities.
- Legal Settlement: A $21 million charge recorded for a jury verdict regarding a 1985 wastewater treatment system installation (company intends to appeal).
- Inventory Provisions: Significant inventory write-downs ($25.3 million in Q2) occurred due to product obsolescence, FDA denials (Trex Medical), and business exits.
Outlook and Reorganization
- Proposed Reorganization: The company announced a plan to consolidate its structure, reducing the number of majority-owned subsidiaries from 23 to 12. This involves taking several subsidiaries private (Thermo Power, ThermoSpectra, Thermo Vision) and merging others into the parent company.
- Cash Flow Outlook: The company expects to incur approximately $35 million in cash expenditures for restructuring in the remainder of 1999 and $53 million in 2000. Management believes proceeds from asset sales will cover these costs and planned stock repurchases.
- Energy Segment Risks: Thermo Ecotek faces significant revenue declines as power sales contracts transition from fixed rates to lower "avoided cost" rates. The Mendota and Woodland plants are expected to operate at reduced income or losses.
Year 2000 Readiness
- The company expects all material IT systems to be compliant by October 1999.
- Total external costs for Y2K remediation are estimated at $14 million.
- Risks include potential disruptions from suppliers and increased warranty claims for older products.
Investor Verification Checklist
- Restructuring Execution: Verify the timeline and actual cash outflows for the $35 million (1999) and $53 million (2000) restructuring commitments.
- Asset Sales: Confirm the completion and proceeds of planned divestitures (ThermoLase spas, Thermo Ecotek facilities, Thermo TerraTech businesses) to ensure they offset restructuring costs.
- Energy Contract Disputes: Monitor the resolution of the PG&E dispute regarding avoided cost rates and the regulatory approval for the Delano facility termination agreement.
- Legal Appeal: Track the status of the appeal regarding the $21 million Rhode Island jury verdict.
- Reorganization Progress: Verify the closing of the mergers to take Thermo Power, ThermoSpectra, and Thermo Vision private as scheduled for Q4 1999.
- Inventory Levels: Assess if inventory provisions were sufficient or if further write-downs are necessary for discontinued product lines.